Effect of pentoxifillyn on COVID-19

Phase 2

• Conditions: COVID-19.; Acute respiratory failure with hypoxia; J96.01

• Registration Number: IRCT20210517051326N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Positive test of PCR test COVID-19
??Age more than 18
SpO2 more than 90%

Exclusion Criteria

Sever COVID-19
Need for treatment with Mechanical ventilation
Need for treatment with high dose corticosteroids
Nausea and vomiting and GIB

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Spo2. Timepoint: 1st, 7th, 28th, 35th day. Method of measurement: Pulseoximetry.